Jonathan Lambert
👤 SpeakerAppearances Over Time
Podcast Appearances
Since 2000, researchers have been studying the health of over 10,000 people exposed in Bangladesh.
They've also tried to limit the amount of arsenic people ingest by labeling contaminated wells and drilling safer ones.
New research in the journal JAMA suggests such interventions can pay off.
People whose exposure went from high to low levels had similar disease risk as those who never drank contaminated water.
Since the early 2000s, a single class of drugs called artemisinin has treated the vast majority of malaria.
Derived from the wormwood plant, artemisinin have saved millions of lives.
But their power to treat malaria is fading in some parts of the globe as the parasite that causes malaria evolves resistance.
Without alternatives, deaths could surge.
But malaria researchers are cheering as a new drug just cleared a big scientific hurdle.
Scanlume, manufactured by Novartis, cured over 97% of patients in a large clinical trial across a dozen African countries.
Researchers presented the results at a meeting of the American Society of Tropical Medicine and Hygiene.
The team hopes for regulatory approval within the next year and a half.
Since the early 2000s, a single class of drugs called artemisinin has treated the vast majority of malaria.
Derived from the wormwood plant, artemisidins have saved millions of lives.
But their power to treat malaria is fading in some parts of the globe as the parasite that causes malaria evolves resistance.
Without alternatives, deaths could surge.
But malaria researchers are cheering as a new drug just cleared a big scientific hurdle.
Ganlum, manufactured by Novartis, cured over 97% of patients in a large clinical trial across a dozen African countries.